{
    "organizations": [],
    "uuid": "334fb7105281000a45f76f787184d56009ed9187",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-athenex-says-patient-enrollment-fo/brief-athenex-says-patient-enrollment-for-two-late-stage-studies-of-actinic-keratosis-treatment-completed-idUSFWN1Q418Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Athenex Says Patient Enrollment For Two Late Stage Studies Of Actinic Keratosis Treatment Completed",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Athenex Inc:\n* ATHENEX ANNOUNCES EARLY COMPLETION OF PATIENTS ENROLLMENT FOR TWO PHASE III CLINICAL STUDIES OF KX2-391 OINTMENT FOR ACTINIC KERATOSIS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T21:26:00.000+02:00",
    "crawled": "2018-02-15T20:47:15.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "athenex",
        "inc",
        "athenex",
        "announces",
        "early",
        "completion",
        "patient",
        "enrollment",
        "two",
        "phase",
        "iii",
        "clinical",
        "study",
        "ointment",
        "actinic",
        "keratosis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}